ArticleJournal of neuro-oncology2024

A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases.

Sebastian Jeising et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.